Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3391112 | Seminarios de la Fundación Española de Reumatología | 2011 | 6 Pages |
Abstract
Pregnant women with autoimmune diseases or anti-Ro or anti-La antibodies should be followed-up by ultrasound during pregnancy to detect any manifestations susceptible to treatment. Currently, there is no consensus on preventive treatment in high-risk patients or in those with a risk of recurrence. Equally, there is insufficient data to confirm the efficacy of currently available preventive treatments. What seems clear is that early detection of congenital heart block should be treated with fluorinated corticosteroids.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Paula Aguilera Peiró, Asunción Vicente Villa, M. Antonia González-Enseñat,